Reduced ovarian cholesterol and steroid biosynthesis along with increased inflammation are associated with high DEHP metabolite levels in human ovarian follicular fluids.

DEHP Endocrine disrupting chemicals Follicular fluid Inflammation Ovary Reproductive health

Journal

Environment international
ISSN: 1873-6750
Titre abrégé: Environ Int
Pays: Netherlands
ID NLM: 7807270

Informations de publication

Date de publication:
15 Aug 2024
Historique:
received: 28 05 2024
revised: 22 07 2024
accepted: 14 08 2024
medline: 23 8 2024
pubmed: 23 8 2024
entrez: 22 8 2024
Statut: aheadofprint

Résumé

The plasticizer di(2-ethylhexyl) phthalate (DEHP) is known to have endocrine-disrupting properties mediated by its many metabolites that form upon exposure in biological systems. In a previous study, we reported an inverse association between DEHP metabolites in the human ovarian follicular fluid (FF) and the responsiveness of the follicles to controlled ovarian stimulation during in vitro fertilization (IVF) treatments. Here, we explored this association further through molecular analysis of the ovarian FF samples. Ninety-six IVF patients from Swedish (N = 48) and Estonian (N = 48) infertility clinics were selected from the previous cohort (N = 333) based on the molar sum of DEHP metabolites in their FF samples to arrive at "high" (mean 7.7 ± SD 2.3 nM, N = 48) and "low" (0.8 ± 0.4 nM, N = 48) exposure groups. Extracellular miRNA levels and concentrations of 15 steroid hormones were measured across FF samples. In addition, FF somatic cells, available for the Estonian patients, were used for RNA sequencing. Differential expression (DE) and interactions between miRNA and mRNA networks revealed that the expression levels of genes in the cholesterol biosynthesis and steroidogenesis pathways were significantly decreased in the high compared to the low DEHP group. In addition, the DE miRNAs were predicted to target key enzymes within these pathways (FDR < 0.05). A decreased 17-OH-progesterone to progesterone ratio was observed in the FF of the high DEHP group (p < 0.05). Additionally, the expression levels of genes associated with inflammatory processes were elevated in the FF somatic cells, and a computational cell-type deconvolution analysis suggested an increased immune cell infiltration into the high DEHP follicles (p < 0.05). In conclusion, elevated DEHP levels in FF were associated with a significantly altered follicular milieu within human ovaries, involving a pro-inflammatory environment and reduced cholesterol metabolism, including steroid synthesis. These results contribute to our understanding of the molecular mechanisms of female reprotoxic effects of DEHP.

Identifiants

pubmed: 39173238
pii: S0160-4120(24)00546-4
doi: 10.1016/j.envint.2024.108960
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

108960

Informations de copyright

Copyright © 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Inge Varik (I)

Department of Chemistry and Biotechnology, Tallinn University of Technology, Tallinn, Estonia.

Runyu Zou (R)

Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands.

Andrea Bellavia (A)

Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USA.

Kristine Rosenberg (K)

Department of Chemistry and Biotechnology, Tallinn University of Technology, Tallinn, Estonia; Nova Vita Clinic, Tallinn, Estonia.

Ylva Sjunnesson (Y)

Department of Clinical Sciences, Division of Reproduction, The Center for Reproductive Biology in Uppsala, Swedish University of Agricultural Sciences, Uppsala, Sweden.

Ida Hallberg (I)

Department of Clinical Sciences, Division of Reproduction, The Center for Reproductive Biology in Uppsala, Swedish University of Agricultural Sciences, Uppsala, Sweden; Department of Animal Biosciences, Division of Reproduction, The Center for Reproductive Biology in Uppsala, Swedish University of Agricultural Sciences, Uppsala, Sweden.

Jan Holte (J)

Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden; Carl von Linné Clinic, Uppsala, Sweden.

Virissa Lenters (V)

Amsterdam Institute for Life and Environment, Section Environmental Health and Toxicology, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.

Majorie Van Duursen (M)

Amsterdam Institute for Life and Environment, Section Environmental Health and Toxicology, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.

Mikael Pedersen (M)

National Food Institute, Technical University of Denmark, Kongens Lyngby, Denmark.

Terje Svingen (T)

National Food Institute, Technical University of Denmark, Kongens Lyngby, Denmark.

Roel Vermeulen (R)

Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands.

Andres Salumets (A)

Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden; Competence Center on Health Technologies, Tartu, Estonia; Department of Gynaecology and Reproductive Medicine, Karolinska University Hospital, Huddinge, Sweden; Department of Obstetrics and Gynaecology, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia.

Pauliina Damdimopoulou (P)

Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden; Department of Gynaecology and Reproductive Medicine, Karolinska University Hospital, Huddinge, Sweden.

Agne Velthut-Meikas (A)

Department of Chemistry and Biotechnology, Tallinn University of Technology, Tallinn, Estonia. Electronic address: Agne.Velthut@taltech.ee.

Classifications MeSH